Ching-I Hung Selected Research

Medically Unexplained Symptoms

1/2020	Comorbidity with more anxiety disorders associated with a poorer prognosis persisting at the 10-year follow-up among patients with major depressive disorder.
1/2019	Reliability and validity of the Depression and Somatic Symptoms Scale among patients with chronic low back pain.
1/2019	Persistent depressive disorder has long-term negative impacts on depression, anxiety, and somatic symptoms at 10-year follow-up among patients with major depressive disorder.
1/2015	The Impacts of Migraine among Outpatients with Major Depressive Disorder at a Two-Year Follow-Up.
1/2015	The impact of the duration of an untreated episode on improvement of depression and somatic symptoms.
1/2015	Depression: An important factor associated with disability among patients with chronic low back pain.
1/2014	Residual symptoms related to physical and panic symptoms at baseline predict remission of depression at follow-up.
2/2013	Migraine predicts physical and pain symptoms among psychiatric outpatients.
7/2012	Correlations between sexual dysfunction, depression, anxiety, and somatic symptoms among patients with major depressive disorder.
3/2012	The cut-off points of the Depression and Somatic Symptoms Scale and the Hospital Anxiety and Depression Scale in detecting non-full remission and a current major depressive episode.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Ching-I Hung Research Topics

Disease

10	Medically Unexplained Symptoms 01/2020 - 03/2012
6	Major Depressive Disorder (Major Depressive Disorders) 01/2020 - 07/2011
4	Pain (Aches) 01/2016 - 02/2012
4	Migraine Disorders (Migraine) 01/2015 - 07/2011
3	Anxiety Disorders (Anxiety Disorder) 01/2020 - 06/2014
1	Depressive Disorder (Melancholia) 01/2019
1	Low Back Pain (Lumbago) 01/2016
1	Sleep Initiation and Maintenance Disorders (Insomnia) 01/2016
1	Metabolic Syndrome (Dysmetabolic Syndrome X) 06/2014

Drug/Important Bio-Agent (IBA)

5	4-amino-4'-hydroxylaminodiphenylsulfone (HADS)IBA 01/2020 - 03/2012
4	3,4-methylenedioxyethamphetamine (MDEA)IBA 01/2019 - 03/2012
1	4-nitro-4'-aminodiphenyl sulfone (NADS)IBA 01/2020
1	Antidepressive Agents (Antidepressants)IBA 02/2012
1	Venlafaxine Hydrochloride (Effexor)FDA LinkGeneric 02/2012

Therapy/Procedure

6	Drug Therapy (Chemotherapy) 01/2019 - 07/2011
1	Aftercare (After-Treatment) 02/2012